These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 283285)

  • 61. Immunofluorescent analysis of expression of the RNA tumor virus major glycoprotein, gp71, on surfaces of virus-producing murine and other mammalian species cell lines.
    Cloyd MW; Bolognesi DP; Bigner DD
    Cancer Res; 1977 Mar; 37(3):922-30. PubMed ID: 65219
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Influence of sensitization with bacterial antigens on the replication of Friend spleen focus-forming virus.
    Flickinger JT; Gentile JM
    Can J Microbiol; 1971 Apr; 17(4):481-6. PubMed ID: 5553350
    [No Abstract]   [Full Text] [Related]  

  • 63. Effect of stimulation of the host defense system by coenzyme Q 10 on dibenzpyrene-induced tumors and infection with Friend leukemia virus in mice.
    Bliznakov EG
    Proc Natl Acad Sci U S A; 1973 Feb; 70(2):390-4. PubMed ID: 4510283
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Ribonucleic acid components of murine sarcoma and leukemia viruses.
    Maisel J; Klement V; Lai MM; Ostertag W; Duesberg P
    Proc Natl Acad Sci U S A; 1973 Dec; 70(12):3536-40. PubMed ID: 4357879
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Friend spleen focus-forming virus production in vitro by a nonerythroid cell line.
    Clarke BJ; Axelrad AA; Housman D
    J Natl Cancer Inst; 1976 Oct; 57(4):853-9. PubMed ID: 1069858
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Efficacy of oral 9-(2-phosphonylmethoxyethyl)-2,6-diaminopurine (PMEDAP) in the treatment of retrovirus and cytomegalovirus infections in mice.
    Naesens L; Neyts J; Balzarini J; Holy A; Rosenberg I; De Clercq E
    J Med Virol; 1993 Feb; 39(2):167-72. PubMed ID: 8387573
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Studies on the role of the host immune response in recovery from Friend virus leukemia. II. Cell-mediated immunity.
    Chesebro B; Wehrly K
    J Exp Med; 1976 Jan; 143(1):85-99. PubMed ID: 1081583
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Inhibition and enhancement of Friend leukemia virus by pyran copolymer.
    Schuller GB; Morahan PS; Snodgrass M
    Cancer Res; 1975 Aug; 35(8):1915-20. PubMed ID: 1149015
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Synthesis of murine leukemia virus proteins differentiating Friend erythroleukemia cells.
    Sherton CC; Dresler SL; Polonoff E; Webb MC; Kabat D
    Cancer Res; 1978 May; 38(5):1426-33. PubMed ID: 273471
    [No Abstract]   [Full Text] [Related]  

  • 70. Helper-independent mink cell focus-inducing strains of Friend murine type-C virus: potential relationship to the origin of replication-defective spleen focus-forming virus.
    Troxler DH; Yuan E; Linemeyer D; Ruscetti S; Scolnick EM
    J Exp Med; 1978 Sep; 148(3):639-53. PubMed ID: 212504
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Factors influencing zidovudine efficacy when administered at early stages of Friend virus infection in mice.
    Sinet M; Desforges B; Launay O; Colin JN; Pocidalo JJ
    Antiviral Res; 1991 Sep; 16(2):163-71. PubMed ID: 1799277
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Inhibition of retrovirus-induced disease in mice by camptothecin.
    Priel E; Aflalo E; Chechelnitsky G; Benharroch D; Aboud M; Segal S
    J Virol; 1993 Jun; 67(6):3624-9. PubMed ID: 8388515
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Impeded progression of Friend disease in mice by an inhibitor of retroviral proteases.
    Lai MH; Tang J; Wroblewski V; Dee AG; Margolin N; Vlahos C; Bowdon B; Buckheit R; Colacino J; Hui KY
    J Acquir Immune Defic Syndr (1988); 1993 Jan; 6(1):24-31. PubMed ID: 8093263
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Inheritance of susceptibility to Friend mouse leukemia virus. X. Separate genetic control of two viruses in Friend virus preparation.
    Odaka T
    Int J Cancer; 1973 May; 11(3):567-74. PubMed ID: 4364718
    [No Abstract]   [Full Text] [Related]  

  • 75. Efficacy of interferon in the treatment of mice with established Friend virus leukemia.
    Wheelock EF; Larke RP
    Proc Soc Exp Biol Med; 1968 Jan; 127(1):230-8. PubMed ID: 4296247
    [No Abstract]   [Full Text] [Related]  

  • 76. Ultraviolet inactivation of murine leukemia and sarcoma viruses.
    Yoshikura H
    Int J Cancer; 1971 Jan; 7(1):131-40. PubMed ID: 5546142
    [No Abstract]   [Full Text] [Related]  

  • 77. Effect of statolon on acute and persistent murine leukemia and sarcoma virus infections.
    Rhim JS; Heubner RJ; Gisin S
    Proc Soc Exp Biol Med; 1969 Jan; 130(1):181-7. PubMed ID: 4302957
    [No Abstract]   [Full Text] [Related]  

  • 78. Biological and clinical effects of a partially thiolated polycytidylic acid (MPC): a potent inhibitor of DNA synthesis in RNA tumor viruses.
    Chandra P; Kornhuber B; Ebener U
    Haematol Blood Transfus; 1979; 23():145-55. PubMed ID: 94573
    [No Abstract]   [Full Text] [Related]  

  • 79. Effects of STAS JLSV5 and silicotungstate on the replication of murine sarcoma virus (Moloney) and poliovirus.
    Jasmin C; Chermann JC; Raybaud N; Bucchini D; Jarrett O; Raynaud M; Mathé G; Plata F
    Bibl Haematol; 1973; 39():381-8. PubMed ID: 4360170
    [No Abstract]   [Full Text] [Related]  

  • 80. Potentiating effect of benzo[a]pyrene and caffeine on Friend viral leukemogenesis.
    Raikow RB; Okunewick JP; Buffo MJ; Jones DL; Brozovich BJ; Seeman PR; Koval TM
    Carcinogenesis; 1981; 2(1):1-6. PubMed ID: 6268320
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.